Reappraising the use of β-lactams to treat tuberculosis.

Reappraising the use of β-lactams to treat tuberculosis.

Item
http://www.wikidata.org/entity/Q38056147
Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Kinetic characterization of hydrolysis of nitrocefin, cefoxitin, and meropenem by β-lactamase from Mycobacterium tuberculosis.Counterattacking drug-resistant tuberculosis: molecular strategies and future directions.Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosisPhosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future
P2860

Reappraising the use of β-lactams to treat tuberculosis.

Item
http://www.wikidata.org/entity/Q38056147
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Reappraising the use of β-lactams to treat tuberculosis.
@en
type
label
Reappraising the use of β-lactams to treat tuberculosis.
@en
prefLabel
Reappraising the use of β-lactams to treat tuberculosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Reappraising the use of β-lactams to treat tuberculosis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932